Recently, we have demonstrated that the histone deacetylase inhibitors valproic acid (VPA) and suberoyl bis-hydroxamic acid (SBHA) act as strong Notch1 activators in MTC cells [36, 37]. Here, NOTCH1 is linked to medullary thyroid gland carcinoma.